全文获取类型
收费全文 | 153443篇 |
免费 | 4900篇 |
国内免费 | 948篇 |
专业分类
159291篇 |
出版年
2021年 | 456篇 |
2020年 | 392篇 |
2019年 | 429篇 |
2018年 | 12564篇 |
2017年 | 11373篇 |
2016年 | 8744篇 |
2015年 | 2729篇 |
2014年 | 2638篇 |
2013年 | 3323篇 |
2012年 | 7841篇 |
2011年 | 16004篇 |
2010年 | 13906篇 |
2009年 | 9691篇 |
2008年 | 12462篇 |
2007年 | 13954篇 |
2006年 | 3077篇 |
2005年 | 3200篇 |
2004年 | 3643篇 |
2003年 | 3429篇 |
2002年 | 3184篇 |
2001年 | 2116篇 |
2000年 | 2072篇 |
1999年 | 1554篇 |
1998年 | 629篇 |
1997年 | 516篇 |
1996年 | 492篇 |
1995年 | 456篇 |
1994年 | 490篇 |
1993年 | 446篇 |
1992年 | 1022篇 |
1991年 | 989篇 |
1990年 | 937篇 |
1989年 | 877篇 |
1988年 | 827篇 |
1987年 | 762篇 |
1986年 | 727篇 |
1985年 | 686篇 |
1984年 | 634篇 |
1983年 | 570篇 |
1982年 | 483篇 |
1981年 | 447篇 |
1980年 | 371篇 |
1979年 | 570篇 |
1978年 | 447篇 |
1977年 | 381篇 |
1975年 | 449篇 |
1974年 | 442篇 |
1973年 | 413篇 |
1972年 | 658篇 |
1971年 | 672篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
11.
12.
Background
Recent studies point to a great diversity of non-ribosomal peptide synthesis systems with major roles in amino acid and co-factor biosynthesis, secondary metabolism, and post-translational modifications of proteins by peptide tags. The least studied of these systems are those utilizing tRNAs or aminoacyl-tRNA synthetases (AAtRS) in non-ribosomal peptide ligation. 相似文献13.
14.
15.
16.
Auranofin affects early events in human polymorphonuclear neutrophil activation by receptor-mediated stimuli 总被引:1,自引:0,他引:1
I Hafstr?m B E Seligmann M M Friedman J I Gallin 《Journal of immunology (Baltimore, Md. : 1950)》1984,132(4):2007-2014
Auranofin, a new oral antirheumatic gold compound, in concentrations achieved therapeutically, inhibits neutrophil phagocytosis, chemotaxis, chemiluminescence, reduction of cytochrome c, and release of lysosomal enzymes. To further characterize the mechanism by which auranofin affects neutrophils, we studied the effects of auranofin on unstimulated properties and functions of neutrophils as well as on rapidly stimulated functions. When examined by electron microscopy, 4 micrograms/ml of auranofin significantly decreased the number of visualized centriole-associated microtubules in resting cells. Furthermore, auranofin inhibited neutrophil spreading on glass and caused a decrease in negative surface charge (electrophoretic mobility). In addition, auranofin inhibited several fmet-leu-phe-stimulated responses such as shape change, increases in centriole-associated microtubules, decreases in surface charge, and elicited membrane potential changes (di-O-C5(3) dye response). Auranofin (1 micrograms/ml) inhibited fmet-leu-phe-stimulated superoxide and hydrogen peroxide production by 80% (p less than 0.05), and also increased the affinity of receptors for fmet-leu-phe (from Ka 0.035 to Ka 0.48, p less than 0.001). Auranofin also affected neutrophil responses to phorbol myristic acetate (PMA). The total amount of PMA-stimulated superoxide production was suppressed by as little as 0.4 micrograms/ml of auranofin, but the lag time for activation was shortened by low concentrations of auranofin (0.5 to 1 microgram/ml). Four micrograms per milliliter of auranofin suppressed the decrease in surface charge induced by PMA. However, auranofin did not influence superoxide production elicited by the ionophore A23187. The results indicate that auranofin affects the earliest detected responses in neutrophil activation by certain receptor-mediated stimuli. 相似文献
17.
The effects of 5-hydroxytryptamine and 5-hydroxytryptophan on 86Rb+ efflux from prelabelled ob/ob-mouse islets were studied to better understand the cellular mechanisms underlying the effects of 5-hydroxytryptamine and 5-hydroxytryptophan on insulin release. 5-Hydroxytryptophan (4 mM) had no effect on 86Rb+ efflux either at a low (3 mM) or at a high (20 mM) d-glucose concentration, whereas 5-hydroxytryptamine (4 mM) stimulated 86Rb+ efflux at both glucose concentrations. These results indicate that 5-hydroxytryptamine may reduce glucose-induced insulin release by inhibiting early steps in the β-cell stimulus-secretion coupling. 相似文献
18.
19.
Prof. Dr. J. Oldenburg S. Rost H. Seidel M. Watzka C.R. Müller-Reible 《Medizinische Genetik》2008,20(2):230-235
The recent identification of VKORC1 has made important contributions to our understanding of the vitamin K cycle. The VKORC1 enzyme was shown to be the molecular target of coumarin drugs. Mutations and polymorphisms in coding and noncoding regions of the VKORC1 gene have been shown to cause both a partial to total coumarin resistance and coumarin sensitivity. Availability of molecular diagnostics (VKORC1, CYP2C9) and drug monitoring by HCPLC (determination of coumarin, vitamin K, and vitamin K epoxide levels) is helpful for detecting hereditary and acquired factors influencing coumarin therapy. In the future, these tools may be instrumental in designing individualized oral anticoagulation therapy regimens. 相似文献
20.